Day of Embryo Transfer for Patients Undergoing In Vitro Fertilization
Embryo Transfer on Day 2 vs. Day 3 After Oocyte Retrieval in Patients Who Plan to Replace All Embryos After an In Vitro Fertilization Cycle
1 other identifier
interventional
242
1 country
1
Brief Summary
We are examining whether pregnancy rates differ based on day of embryo transfer in patients who replace all available embryos after an In vitro Fertilization (IVF) cycle. Patients must be undergoing IVF treatment at Stanford University and patients will not receive compensation for their participation (no medical costs covered or patient payment for participation).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2007
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 1, 2008
CompletedFirst Posted
Study publicly available on registry
February 14, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2009
CompletedNovember 28, 2016
July 1, 2011
2.2 years
February 1, 2008
November 23, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Pregnancy rates
1 year
Secondary Outcomes (2)
Live birth rates
1 year
Multiple gestation rates
1 year
Study Arms (2)
Day 2 embryo transfer
EXPERIMENTALEmbryos are transferred 2 days after fertilization.
Day 3 embryo transfer
ACTIVE COMPARATORStandard of care for women undergoing IVF with a limited number of embryos is to transfer all embryos on Day 3 after fertilization
Interventions
Embryos are transferred 1 day prior to standard of care
Eligibility Criteria
You may qualify if:
- Patients undergoing fresh IVF cycle at Stanford Fertility Center who plan on replacing all available embryos.
You may not qualify if:
- Patients that do not meet above criteria.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford University School of Medicine
Stanford, California, 94305, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Lora K Shahine
Stanford University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor
Study Record Dates
First Submitted
February 1, 2008
First Posted
February 14, 2008
Study Start
January 1, 2007
Primary Completion
March 1, 2009
Study Completion
March 1, 2009
Last Updated
November 28, 2016
Record last verified: 2011-07